Register

Forgot your password?

Forgot your username?

Mast Therapeutics, Inc. Biotech Specialty Pharma

12390 El Camino Real, Suite 150
San Diego, CA 92130 United States
phone:phone
fax:fax
Click for website
Research Sector Biotech Specialty Pharma
Summary Description Hematology and oncology-focused biopharmaceutical company with three clinical-stage product candidates.

Click here for Financial Data Keywordssickle cell disease, microvascular, hematology, oncology, shock, copolymer, chemotherapy, nonsmallcelllungcancer, lungcancer, breastcancer, solidtumor, cytoprotective, ischemia, acutelimbischemia

Description

Mast Therapeutics, Inc. (NYSE MKT: MSTX) is a publicly traded biopharmaceutical company headquartered in San Diego, California. The Company is leveraging the MAST (Molecular Adhesion and Sealant Tech......view more

Products / Services

Mast's lead product candidate, MST-188 (formerly ANX-188) is a purified form of a nonionic, triblock copolymer (poloxamer 188). It binds to hydrophobic surfaces on damaged cells and improves membrane ......view more


Technology / Differentiation

MST-188 is an investigational agent, formulated using a purified form of poloxamer 188. Substantial research has demonstrated that poloxamer 188 has cytoprotective and hemorrheologic properties and in...view more

Status

- The company is currently recruiting patients with sickle cell disease to participate in EPIC, its phase 3 trial of MST-188. At the end of March, 2013, the European Commission designated MST-188 as a...view more



2014-10-31-6737